
75
Contribución de la imagenología en la detección y seguimiento de enfermedades no transmisibles
Retos de la Ciencia, 10(22), 65-75.
ISSN 2602-8237
Nam, D., Barrack, R. L., & Potter, H. G. (2014). What are the advantages and disadvantages of
imaging modalities to diagnose wear-related corrosion problems? Clinical
Orthopaedics and Related Research, 472(12), 3665–3673.
https://doi.org/10.1007/s11999-014-3579-9
Sim, A., Kaza, E., Singer, L., & Rosenberg, S. (2020). A review of the role of MRI in diagnosis
and treatment of early-stage lung cancer. Clinical and Translational Radiation
Oncology, 24, 16–22. https://doi.org/10.1016/j.ctro.2020.06.002
Bak, S. H., Kim, C., Kim, C. H., Ohno, Y., & Lee, H. Y. (2022). Magnetic resonance imaging for
lung cancer: A state-of-the-art review. Precision and Future Medicine, 6(1), 49–77.
https://doi.org/10.23838/pfm.2021.00170
Tarnoki, D. L., Karlinger, K., & Ridge, C. A. (2024). Lung imaging methods: Indications,
strengths and limitations. Breathe, 20(3), 230127. https://acortar.link/WBt2mj
Kusmirek, J., Magnusson, J., & Perlman, S. (2020). Current applications for nuclear medicine
imaging in pulmonary disease. Current Pulmonology Reports, 9(3), 82–95.
https://doi.org/10.1007/s13665-020-00253-2
Totzeck, M., Aide, N., Bauersachs, J., Bucerius, J., Georgoulias, P., Herrmann, K., Hyafil, F.,
Kunikowska, J., Lubberink, M., Nappi, C., Rassaf, T., Saraste, A., Sciagra, R., Slart, R.
H. J. A., Verberne, H., & Rischpler, C. (2023). Nuclear medicine in the assessment and
prevention of cancer therapy-related cardiotoxicity: Prospects and proposal of use by
the European Association of Nuclear Medicine (EANM). European Journal of Nuclear
Medicine and Molecular Imaging, 50(3), 792–812. https://acortar.link/MDHYuC
Rassaf, T., Totzeck, M., Backs, J., Bokemeyer, C., Hallek, M., Hilfiker-Kleiner, D., et al. (2020).
Onco-cardiology: Consensus paper of the German Cardiac Society, the German
Society for Pediatric Cardiology and Congenital Heart Defects and the German Society
for Hematology and Medical Oncology. Clinical Research in Cardiology, 109(10),
1197–1222. https://doi.org/10.1007/s00392-020-01636-7
Zhang, S., Wang, X., Gao, X., Chen, X., Li, L., Li, G., Liu, C., Miao, Y., Wang, R., & Hu, K.
(2025). Radiopharmaceuticals and their applications in medicine. Signal Transduction
and Targeted Therapy, 10(1), 1. https://doi.org/10.1038/s41392-024-02041-6
Li, D., Liu, Y., Yang, Z., Li, N., & Zhu, H. (2025). Recent advances of nuclear medicine for
tumor precision medicine. Precision Medicine and Engineering, 2(2), 100032.
https://doi.org/10.1016/j.preme.2025.100032
Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. The New England
Journal of Medicine, 372(9), 793–795. https://doi.org/10.1056/NEJMp1500523
Wei, L., Yang, R. N., Xu, P., Jin, C. Q., & Xu, L. (2024). Trend observation: Development trend
analysis in the field of precision medicine. Bulletin of Chinese Academy of Sciences,
36, 63–71. https://doi.org/10.13376/j.cbls/2024009
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A.
(2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality
worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3),
229–263. https://doi.org/10.3322/caac.21834
Pang, X. X., Huo, Y., & Wang, R. F. (2016). Molecular imaging of nuclear medicine in the era
of precision medicine. Labeled Immunoassays and Clinical Medicine, 23, 1119–1122.
https://short.do/pk1yYI